Gastrointestinal Cancer Archives | VJOncology

The GI Cancer Channel on VJOncology is supported by Seagen. This supporter has no influence over the production of the content.

View overview page

How can immunotherapies successfully target MSS colorectal cancer?

Benny Johnson • 17 Apr 2023

BASECAMP-1: progress in developing CAR-T cell therapy for solid tumors

Diane Simeone • 4 Apr 2023

BASECAMP-1: developing Tmod CAR T-cell therapy for solid tumors

Diane Simeone • 4 Apr 2023

Challenges in developing cellular therapies in solid tumors

Benjamin Schlechter • 21 Jan 2023

Mechanisms of immune evasion in pancreatic cancer and what strategies to enhance immunotherapies

Kim Anna Reiss • 21 Jan 2023

Current hurdles in developing CAR-T therapies for gastrointestinal tumors

J. Randolph Hecht • 20 Jan 2023

Anti-HER2 autologous TAC T cells in relapsed or refractory solid tumors

Benjamin Schlechter • 21 Jan 2023

Evaluating the emerging role of cellular therapies in GI cancers

David Bing Zhen • 19 Jan 2023

What does the future hold for CAR-T cells in gastric cancers?

David Bing Zhen • 19 Jan 2023

Identifying patients with solid tumors for HLA loss of heterozygosity

J. Randolph Hecht • 20 Jan 2023

LB1908: a novel CAR-T cell therapy targeting claudin 18.2 in GI malignancies

David Bing Zhen • 19 Jan 2023

Claudin 18.2 as an emerging target in gastrointestinal cancers

David Bing Zhen • 19 Jan 2023

Tmod cellular logic gate as a solution to on-target, off-tumor toxicity in CAR-T for solid tumors

J. Randolph Hecht • 15 Nov 2022

Updates in targeting mesothelin-expressing solid tumors

Mitchell Ho • 24 Oct 2022

Emerging cell therapies for liver cancer

Mitchell Ho • 24 Oct 2022

Enhancing CAR-T cell efficacy in solid tumors

Andras Heczey • 8 Nov 2022

1
2
3
Next